Sever Pharma Solutions
Jing Dai is an experienced professional in the field of chemistry and biomedical science, currently serving as a Development Scientist at Sever Pharma Solutions. Prior roles include serving as a Postdoctoral Researcher at KTH Royal Institute of Technology and a Material Developer/Product Developer at Biofiber Tech Sweden AB. Jing has also held positions as a Project Lead for Marie Curie Innovative Training Networks, as well as a Teacher and Mentor at the Royal Institute of Technology. An educational background includes a Ph.D. in Chemistry from KTH Royal Institute of Technology, completed in 2018, and a Master of Engineering in Biomedical Science from Kangwon National University, attained from 2010 to 2012.
Sever Pharma Solutions
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey. We add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions. By providing a complete value chain, from development to sourcing and worldwide commercial supply, we can offer you an optimized end-to-end solution. And as a committed long-term partner with a strong focus on creating a commercial product, we put all our resources at work for you to the finishing line – and beyond. Together with our global GMP compliance, regulatory services, and market access strategies, we can secure that your products will benefit patients all over the world.